HealthDay News — Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online Dec. 17 in the Journal of Racial and Ethnic Health ...

Obesity rates in the UK might start falling by the end of 2024 due to the rising use of weight loss medications like Wegovy and Mounjaro, according to Simple Online Pharmacy, Sky News reports.

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, the Centers for ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Desjardins Insurance is partnering with Constant Health to launch weight management coverage of obesity medications (OMs) in ...

Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...

Obesity is a common problem in society at large, but is seen at higher rates among persons living with mental disorders. The ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

Obesity is a major public health challenge in the United States, with more than 40% of Americans affected. This chronic ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...